BGV (BioGeneration Ventures)
Palo Alto, California
Founded:2006
Firm Location:Palo Alto, California • Amsterdam, Netherlands • San Francisco Bay Area • Netherlands • Naarden, Netherlands
Investor Firms That Co-Invest with BGV (BioGeneration Ventures)
Takwin VenturesInterWestMorpheus VenturesWavemaker Three-Sixty HealthPartech VenturesNovartis Venture FundMDC Ventures (formerly KBS Ventures)Speciale InvestAngel investorWestWave CapitalThe D. E. Shaw GroupEmergent VenturesG2VPInventus Capital PartnersBayern KapitalAndreessen HorowitzToyota VenturesWestlake Village BioPartnersDNX VenturesSeventure PartnersForbionAndera PartnersBrandon Capital PartnersAlpha Intelligence CapitalAvaana CapitalSenseAI VenturesINKEF CapitalFusion FundCanvas VenturesPlug and Play Tech CenterPelion Venture PartnersGV (Google Ventures)Emerging Venture Capitalists Association (EVCA)ForgePoint CapitalStandard CapitalMDVAglaia Oncology FundsEmergence Capital PartnersHotmailUPWARD - Uniting Professional Women Accelerating Relationships & DevelopmentJohnson & Johnson Innovation JJDC IncAlex & ThiagoOboJolly VC
BGV (BioGeneration Ventures) Team
Investors in SF Bay Area (CA)
Investors in Enterprise (Series A), Investors in Enterprise (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Enterprise (Series A), Investors in Enterprise (Seed)
Investors in Naarden (Netherlands)
Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in Consumer Health (Seed), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Investors in Naarden (Netherlands)
Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Investors in Naarden (Netherlands)
Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Investors in Naarden (Netherlands)
Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Investors in Naarden (Netherlands)
Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Investors in AR/VR (Series A), Investors in MarketingTech (Series A), Investors in Food and Beverage (Series A), Investors in Web3/Blockchain (Series A), Investors in Sales & CRM (Series A), Investors in Robotics (Series A), Investors in Logistics (Series A), Investors in AI (Series A), Investors in Enterprise (Series A), Investors in San Francisco Bay Area (Other Lists), Investors in SaaS (Series A)
Investors in Naarden (Netherlands)
Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Investors in Naarden (Netherlands)
Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Investors in Naarden (Netherlands)
Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Investors in Naarden (Netherlands)
Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Investors in Naarden (Netherlands)
Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)